# A Randomized Trial of Intratympanic Drug Delivery: Evaluating the Efficacy and Safety of Dexamethasone-Loaded Exosomes Versus Standard Therapy in Acute Sensorineural Hearing Loss.

> **NCT07568184** · NA · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 30 (estimated)

## Conditions studied

- Sensori-Neural Deafness
- Exosomes

## Interventions

- **DRUG:** exosomes derived from human umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT07568184
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-03
- **Primary completion:** 2027-04
- **Final completion:** 2027-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07568184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07568184, "A Randomized Trial of Intratympanic Drug Delivery: Evaluating the Efficacy and Safety of Dexamethasone-Loaded Exosomes Versus Standard Therapy in Acute Sensorineural Hearing Loss.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07568184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*